Senior UK official asks whether pause in pharma sector spending is ‘co-ordinated’
found
a story from Financial Times ✅ › Financial Times
Eli Lilly, Merck and AstraZeneca have all said in recent weeks that they plan to roll back investment
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.